Products - Urinary incontinence | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
View all What we do
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 31 products

Date | Title

Axonics sacral neuromodulation system for treating refractory overactive bladder (MTG50)
Product type:
Guidance
Programme:
Medical technologies guidance
Published:
3 September 2020
Bedwetting in children and young people (QS70)
Product type:
Quality standard
Published:
18 September 2014
Bedwetting in under 19s (CG111)
Product type:
Guidance
Programme:
Clinical guideline
Published:
27 October 2010
BladderScan BVI 9400 3D portable ultrasound scanner for measuring bladder volume (MIB50)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
22 January 2016
Bone-anchored cystourethropexy (IPG18)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 November 2003
Extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women (IPG576)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
22 March 2017
High intensity focused electromagnetic (HIFEM) energy to target the pelvic floor muscles
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Intramural urethral bulking procedures for stress urinary incontinence in women (IPG138)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 November 2005
Laparoscopic augmentation cystoplasty (including clam cystoplasty) (IPG326)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
16 December 2009
Laparoscopic cystectomy (IPG287)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
25 February 2009
Mirabegron for treating symptoms of overactive bladder (TA290)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
26 June 2013
MT547 QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Pelvic floor dysfunction
Status:
Awaiting development
Expected publication date:
TBC
Pelvic floor dysfunction: prevention and non-surgical management (NG210)
Product type:
Guidance
Programme:
NICE guideline
Published:
9 December 2021
Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome (IPG362)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 October 2010
QuickChange Incontinence Wrap for urinary incontinence in men (MIB237)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
24 November 2020
Retrograde urethral sphincterometry (IPG167)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 April 2006
Sacral nerve stimulation for urge incontinence and urgency-frequency (IPG64)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 June 2004
Single-incision short sling mesh insertion for stress urinary incontinence in women (IPG566)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
12 October 2016
Single-incision short sling mesh insertion for stress urinary incontinence in women
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Transcutaneous electrical neuromuscular stimulation for urinary incontinence (IPG735)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
24 August 2022
Transvaginal laser therapy for stress urinary incontinence (IPG696)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 May 2021
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MIB210)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
17 March 2020
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
TUC Safety Valve to prevent balloon inflation in the urethra during transurethral catheterisation (MT512)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Urinary incontinence and pelvic organ prolapse in women: management (NG123)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
24 June 2019
Published:
2 April 2019
Urinary incontinence in neurological disease: assessment and management (CG148)
Product type:
Guidance
Programme:
Clinical guideline
Last updated:
2 October 2023
Published:
8 August 2012
Urinary incontinence in women (QS77)
Product type:
Quality standard
Last updated:
9 December 2021
Published:
22 January 2015
Urolon, (MT821)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Vibegron for treating symptoms of overactive bladder syndrome (TA999)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
4 September 2024